Topic 11 — Sexually Transmitted Infections: Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention

Connect the major STI concepts into one rapid-revision pathway: exposure → infection → presentation → diagnosis → treatment and prevention.

1. THE TOPIC IN ONE CONNECTED FLOW

Sexually transmitted infections differ in their organisms and manifestations, but they share a common public-health sequence. Exposure allows infection to become established; disease may remain silent or produce characteristic findings; appropriate testing identifies the infection; and effective treatment, vaccination, screening and partner management interrupt complications and further transmission.

Exposure & Risk
Sexual contact, infected blood, shared injecting equipment or vertical transmission

→

Organism Establishes Infection
HIV, T. pallidum, gonococcus, chlamydia or HPV infect susceptible tissues

→

Silent or Active Disease
Infection may remain asymptomatic or produce local and systemic manifestations

→

Clinical Pattern
Immune deficiency, genital lesions, urethritis, cervicitis or epithelial change

→

Diagnostic Clue
Serology, antigen/nucleic-acid testing, NAAT, culture or cervical screening

→

Treatment & Control
Appropriate therapy, ART, vaccination, screening and partner management

→

Outcome
Control prevents transmission, immune damage, reproductive complications and malignant progression

2. KEY CLINICAL CONNECTIONS

HIV: Infection → Immune Failure → Control

HIV enters CD4 cells → reverse transcription and integration → progressive CD4-cell loss → impaired cell-mediated immunity → opportunistic disease.

Validated HIV testing → confirmation of infection → viral load/CD4 assessment → combination ART → viral suppression and reduced transmission.

Syphilis & Bacterial Genital Infection

T. pallidum inoculation → primary lesion → dissemination → secondary disease → latency → possible late complications; serology links the clinical stage to diagnosis.

Gonorrhea/chlamydia at mucosal sites → urethritis or cervicitis → NAAT-based detection → treatment plus partner care → reduced ascending or disseminated complications.

HPV: Wart Disease vs Oncogenic Disease

Low-risk HPV → benign epithelial proliferation → genital warts → local wart treatment, although viral infection may persist.

Persistent high-risk HPV → epithelial dysplasia → cervical cancer risk → HPV vaccination plus cervical screening reduces disease burden.

3. AIM HIGH-YIELD INTEGRATION REVIEW

⭐ Asymptomatic infection → delayed diagnosis → ongoing transmission; therefore exposure history and appropriate testing are central to STI control.

⭐ HIV replication in CD4 cells → progressive cellular immunodeficiency; combination ART suppresses replication and permits immune recovery.

Early HIV infection → antibodies may not yet be detectable → antigen or nucleic-acid detection can become diagnostically important.

⭐ Syphilis changes with time → primary local disease → secondary systemic dissemination → latency → possible neurological, cardiovascular or gummatous disease.

Gonorrhea and chlamydia → mucosal infection may be clinically silent → untreated infection can persist, spread and produce important complications.

NAAT → detects gonococcal or chlamydial genetic material at the relevant anatomical site → supports diagnosis even when symptoms are limited.

⭐ Low-risk HPV → genital warts, while persistent high-risk HPV → dysplasia and malignant potential; prevention therefore combines vaccination and screening.

Patient treatment + partner management + prevention → fewer untreated reservoirs → less reinfection and reduced community transmission.

AIM Exam Trap: Condylomata acuminata are HPV-related genital warts, whereas condylomata lata are manifestations of secondary syphilis.